Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 561

Results For "CE"

8162 News Found

Xyall and Indica Labs forge collaboration to transform precision oncology workflows
News | April 25, 2023

Xyall and Indica Labs forge collaboration to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology


Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr
News | April 25, 2023

Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr

The business and product range of Ipca and that of Unichem complements each others business and product range


Aster RV Hospital launch needleless injections in South India
News | April 25, 2023

Aster RV Hospital launch needleless injections in South India

A special technique of jet injection is used to make vaccination almost painless and totally needleless.


Huge milestones made towards Zero Malaria goal, says GlobalData
News | April 25, 2023

Huge milestones made towards Zero Malaria goal, says GlobalData

Malaria is a life-threatening parasitic infection that is spread by the bites of mosquitoes carrying the Plasmodium parasite


Apollo launches Genomics Institute in Chennai
Biotech | April 25, 2023

Apollo launches Genomics Institute in Chennai

Apollo continues to invest in genomics technology and research for better patient care


Aurisco expands Oligonucleotide capacity
News | April 24, 2023

Aurisco expands Oligonucleotide capacity

The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.


USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013
Drug Approval | April 24, 2023

USFDA lifts clinical hold on Phase 3 investigational new drug application for MaaT013

This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology


Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData
News | April 24, 2023

Tissue engineered skin substitutes market to reach $3 billion by 2033, forecasts GlobalData

The burden of treating chronic wounds is growing rapidly due to increasing health care costs


Cadila plans an injectable manufacturing facility in collaboration with Russia
News | April 22, 2023

Cadila plans an injectable manufacturing facility in collaboration with Russia

The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries


CCI approves Berhyanda's acquisition of Suven Pharma
News | April 22, 2023

CCI approves Berhyanda's acquisition of Suven Pharma

The acquisition would be by way of a share purchase agreement dated Dec. 26, 2022.